Deinove enters into collaboration with bioMérieux to discover new antibiotics

June 28, 2018
DEINOBIOTICS/DEINOVE

Montpellier, 28 June, 2018 (5:35 pm CEST) – DEINOVE (Euronext Growth Paris: ALDEI), a biotech company that discovers, develops, and produces high-value compounds from rare bacteria, announces a collaboration with bioMérieux, a major player in in vitro diagnostics, to explore new strains and multiply opportunities to discover new antibiotics.

Press Release available here: